During the past decade, Western Nephrology and Metabolic Bone Disease, PC conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 7 clinical trials were completed, i.e. on average, 175% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Western Nephrology and Metabolic Bone Disease, PC" #1 sponsor was "Keryx Biopharmaceuticals" with 3 trials, followed by "Reata Pharmaceuticals, Inc." with 3 trials sponsored, "Novartis" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Shire" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Western Nephrology and Metabolic Bone Disease, PC" #1 collaborator was "Collaborative Study Group (CSG)" with 1 trials as a collaborator, "Harvard University" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Massachusetts General Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Western Nephrology and Metabolic Bone Disease, PC" are "Hyperphosphatemia" (3 trials), "Autosomal Dominant Polycystic Kidney" (2 trials), "Chronic Kidney Diseases" (2 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Kidney Failure" (2 trials). Many other conditions were trialed in "Western Nephrology and Metabolic Bone Disease, PC" in a lesser frequency.

Most popular intervention types in "Western Nephrology and Metabolic Bone Disease, PC" are "Drug" (12 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bardoxolone methyl oral capsule" (2 trials), "Epoetin Hospira" (2 trials), "Placebo" (2 trials), "Placebo oral capsule" (2 trials) and "ferric citrate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Western Nephrology and Metabolic Bone Disease, PC" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Western Nephrology and Metabolic Bone Disease, PC". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Western Nephrology and Metabolic Bone Disease, PC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Western Nephrology and Metabolic Bone Disease, PC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".